ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
90 hedge funds and large institutions have $189M invested in Endocyte, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
Holders
90
Holding in Top 10
1
Calls
$3.36M
Puts
$4M
Top Buyers
| 1 | +$6.06M | |
| 2 | +$4M | |
| 3 | +$3.46M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.97M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.31M |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.83M | |
| 3 | -$1.47M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$1.15M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.1M |